+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhancement of cisplatin cytotoxicity by all trans retinoic acid on human ovarian carcinoma cell lines



Enhancement of cisplatin cytotoxicity by all trans retinoic acid on human ovarian carcinoma cell lines



Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 293




(PDF emailed within 1 workday: $29.90)

Accession: 031252875

Download citation: RISBibTeXText


Related references

Enhancement of cisplatin cytotoxicity by all trans retinoic acid in a human ovarian carcinoma cell line is characterized by apoptosis. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 414, 1996

Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines. British Journal of Cancer 75(3): 333-340, 1997

Differential effects of all-trans retinoic acid and docosahexaenoic acid on cisplatin-induced cytotoxicity and apoptosis in cisplatin sensitive and resistant human embryonal carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 401, 1996

Modulation of cisplatin cytotoxicity by human recombinant interferon gamma and all trans-retinoic acid in four human ovarian cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 295, 1993

Antiproliferative effects of interferon alpha-2a in combination with all trans retinoic acid or cisplatin in human ovarian carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 293, 1996

Cytotoxic effect of interferon-alpha2a in combination with all-trans retinoic acid or cisplatin in human ovarian carcinoma cell lines. Anti-Cancer Drugs 9(3): 229-238, 1998

Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell line. International Journal of Cancer 55(3): 442-447, 1993

Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: Relationship with induction of differentiation and retinoic acid receptor expression. International Journal of Cancer 56(5): 743-748, 1994

All trans retinoic acid induces heterogeneous responsiveness on human ovarian carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 42, 1993

Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line. Cancer ChemoTherapy and Pharmacology 41(6): 469-476, 1998

Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines. Journal of Interferon Research 13(1): 25-32, 1993

Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line. European Journal of Cancer 36(18): 2411-2419, 2000

Effect of all-trans retinoic acid on the apoptosis induced by cisplatin and Taxol in ovarian cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 23, 1996

Mechanisms of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Biochemical Society Transactions 18(4): 622, 1990

Antiproliferative effects of alpha and beta interferon in combination with 5 fluorouracil cisplatin and cis and trans retinoic acid in two non small cell lung carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 32: 228, 1991